Mark Reuter advocates for business clients in transactions, proceedings and conflicts regulated by federal and state securities laws and stock exchange rules. A partner in the firm’s business representation and transactions group, Mark has extensive experience representing publicly traded and privately owned clients in strategic transactions, executive compensation and equity arrangements, corporate governance, reporting, internal investigations, and administrative actions. Mark regularly advises management, boards and their committees, and other stakeholders in mergers and acquisitions, public offerings, follow-on equity offerings, investment grade and convertible debt offerings, tender offers, private placements, proxy solicitations, and issues arising under the Dodd-Frank Act, the Sarbanes-Oxley Act, and state corporate law.
Mark represents American Financial Group, Inc., AtriCure, Inc., Fifth Third Bancorp, Hemagen Diagnostics, Inc., Indiepub Entertainment, Inc., Infinity Property and Casualty Corporation, LSI Industries Inc., Meridian Bioscience, Inc., and Multi-Color Corporation.